Grifols (NASDAQ:GRFS) Rating Lowered to Hold at StockNews.com

StockNews.com lowered shares of Grifols (NASDAQ:GRFS – Free Report) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning. Separately, Morgan Stanley upgraded Grifols from an equal weight rating to an overweight rating in a research report on Wednesday, April 12th. Four equities research analysts have rated […]

Related Keywords

United States ,Blackrock ,Nova Scotia ,Canada ,Spain ,Albutein Flexbag ,Vistaseal Veraseal ,Us Bancorp ,Morgan Stanley ,Raymond James Associates ,Blackrock Inc ,Advisor Group Holdings Inc ,Financial Services Group Inc ,Nasdaq ,Grifols Company Profile ,Free Report ,Group Holdings ,Services Group ,Get Free Report ,Gamunexc Immune Globulin Injection ,Flebogamma Immune Globulin Intravenous ,Xembify Immune Globulin Subcutaneous ,Immune Globulin ,Lynspad Alpha ,Proteinase Inhibitor ,Human Albumin ,Plasbumin Albumin ,Grifols Daily ,Grifols ,Nasdaq Grfs ,Grfs ,Medical ,Downgrade ,Stocknews Com ,